Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Alkermes Stock (NASDAQ: ALKS) stock price, news, charts, stock research, profile.
You can purchase shares of Alkermes (NASDAQ:ALKS) through any online brokerage.
Other companies in Alkermes’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE) and Ionis Pharmaceuticals (NASDAQ:IONS).
Alkermes has a consensus price target of $34.00.
The stock price for Alkermes (NASDAQ: ALKS) is $31.5136 last updated December 20, 2024 at 6:34 PM EST.
There are no upcoming dividends for Alkermes.
Alkermes’s Q4 earnings are confirmed for Thursday, February 13, 2025.
There is no upcoming split for Alkermes.
Alkermes is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.